Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000925421-22-000002
Filing Date
2022-02-17
Accepted
2022-02-17 13:21:17
Documents
1
Effectiveness Date
2022-02-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7475
  Complete submission text file 0000925421-22-000002.txt   8511
Mailing Address 11045 COMMERCIAL PARKWAY CASTROVILLE CA 95012
Business Address 11045 COMMERCIAL PARKWAY CASTROVILLE CA 95012 831-632-0913
Biopharmaceutical Research Co (Filer) CIK: 0001826834 (see all company filings)

EIN.: 820650107 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-434007 | Film No.: 22646906